Sage Journals: Discover world-class research

Open access

Review article

First published 2022

RET kinase inhibitors for RET -altered thyroid cancers

Danica M. Vodopivec, Mimi I. Hu

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024-01

Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield [...]

Thyroid®

Open access

Research article

First published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET -altered thyroid cancers: results from the phase II LIBRETTO-321 study

Xiangqian Zheng, Qinghai Ji, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Retricted access

Letter

First published 2024-09

Erectile Dysfunction in Patients Treated with Selpercatinib for RET -Altered Thyroid Cancer

Antonio Matrone, Matthias Kroiss, Matti L. Gild [...]

Thyroid®

Open access

Review article

First published 2023

Precision oncology with selective RET inhibitor selpercatinib in RET -rearranged cancers

Mohamed A. Gouda, Vivek Subbiah

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2022-06

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers

Lucy X. Ma, Osvaldo Espin-Garcia, Philippe L. Bedard [...]

Thyroid®

Retricted access

Research article

First published 2010-07

Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer

Mingzhao Xing

Thyroid®

Retricted access

Research article

First published 2011-04

Prevalence,Clinicopathologic Features,and Somatic Genetic Mutation Profile in Familial Versus Sporadic Nonmedullary Thyroid Cancer

Willieford Moses, Julie Weng, Electron Kebebew

Thyroid®

Retricted access

Research article

First published 2005-06

Multiple Signaling Pathways Converge on β-Catenin in Thyroid Cancer

Phillip H. Abbosh, Kenneth P. Nephew

Thyroid®

Retricted access

Research article

First published 2009-11

High Iodine Concentration Attenuates RET/PTC3 Oncogene Activation in Thyroid Follicular Cells

Ana Paula Zen Petisco Fiore, Cesar Seigi Fuziwara, Edna Teruko Kimura

Thyroid®

Search results